NEW YORK (GenomeWeb News) – Building on an existing relationship, Agilent Technologies and Chungnam National University in South Korea today announced new initiatives in the area of glycomics.

The new research will aim to develop new biomarkers and new therapeutic antibodies against diseases such as cancer, they said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.